Information for Doctors

Are you a DOCTOR looking for more details about our practice?

Thoracic Medicine

Think you might have a breathing disorder or just looking for more information?

Sleep Medicine

Latest News

In a study titled "Interactions between Sleep Habits and Self-Control," Clemson psychologists concluded a sleep-deprived individual is at increased risk for succumbing to impulsive desires, inattentiveness and questionable decision-making.

Read more...
 

A University of Michigan study found power naps or extended breaks during the day could ease frustration, help offset impulsive behaviour and increase workplace safety.

Read more...
 

The Commonwealth’s Chief Medical Officer has sought the assistance of Australian Colleges and other health agencies to further publicise the international situation regarding the spread of MERS.

Read more...
 

Philips ASV Device Recall for Product Correction

Read more...
 

Researchers say that pulmonary rehabilitation (PR) programmes for patients with moderate to severe chronic obstructive pulmonary disease (COPD) should include sleep assessment.

Read more...
 

Heavy snoring and sleep apnoea may be linked to memory and thinking decline at an earlier age.

Read more...

Current trials

Patients needed for patent 1, patent 2 and chest clinical trials

PATENT 1, PATENT 2 and CHEST trials are currently underway at the Wesley Pulmonary Hypertension Unit and new patients are required.  We are trialing Riociuguat - a direct stimulator of the soluable Guanylate Cyclase which plays a significant role in the nitric oxide pathway and is intended for the treatment of PH. The trial is in association with Bayer and Wesley Research Institute.

In PATENT 1 & 2 trials, the patient can already be on therapy with an endothelin receptor antagonists (bosentan, sitaxentan or ambrisetan) or naïve to PAH therapy.

The CHEST trial is using the same agent for non-operable chronic thromboembolic disease related PAH.  (CTEPH)

We are accepting patients now for these trials by referral.

About The Wesley Pulmonary Hypertension Unit

The Wesley Pulmonary Hypertension Unit (WPHU) has established itself as one of the largest specialised treatment centres in Queensland.  In just 18 months of operation, the clinic has reviewed patients for treatment and have been actively enrolling patients into international clinical trials.  The treatment programs include monotherapy and combination treatments in keeping with the best available therapies for PAH.

Treatments Available

All PBS funded medications for monotherapy

Combination therapy – funded or via clinical trials

Clinical Trials with WRI

PATENT 1 and 2 trials

CHEST trial

Diagnostic Procedures

Cardiac Catherterisation
Nuclear imaging
MRI and CT
Echocardiograms
Complex Lung Testing CPET
Diagnostic Sleep Studies
6 MWT


The Wesley Pulmonary Hypertension Unit multidisciplinary team includes:

Dr John Feenstra
Thoracic and Sleep Physician
P:  (07) 3876 9033
F:  (07) 3871 3222
E:  This e-mail address is being protected from spambots. You need JavaScript enabled to view it
W: www.thoracicandsleep.com.au

Dr Andrew Scott
Thoracic and Sleep Physician
P:  (07) 3876 8405
F:  (07) 3870 3212
E:   This e-mail address is being protected from spambots. You need JavaScript enabled to view it
W:  www.thoracicandsleep.com.au

Dr David Cross
Cardiologist
P:  (07) 3858 8600
F:   (07) 3870 4917
E:   This e-mail address is being protected from spambots. You need JavaScript enabled to view it
W: www.heartcarepartners.com.au

Helen Woodhouse, CNC
WPHU Coordinator
P:  0404 650 281
F:  (07) 3871 3222
E:   This e-mail address is being protected from spambots. You need JavaScript enabled to view it

© copyright 2010 | All Rights Reserved | Web Design Brisbane by iFactory